Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin

被引：0
|
作者：
Clarisse Eveno
Guillaume Passot
Diane Goéré
Philippe Soyer
Etienne Gayat
Olivier Glehen
Dominique Elias
Marc Pocard
机构：
[1] Hôpital Lariboisière-AP-HP & Université Diderot-Paris 7,Department of Digestive Disease
[2] Hôpital Lariboisière-AP-HP,UMR INSERM 965
[3] Centre Hospitalier Lyon Sud,Paris 7 “Angiogenèse et recherche translationnelle”
[4] Université Lyon,Department of Digestive Surgery
[5] Université Lyon,Department of Digestive Surgery
[6] Institut Gustave Roussy,Department of Surgical Oncology
[7] Hôpital Lariboisière-AP-HP & Université Diderot-Paris 7,Department of Abdominal & Interventional Imaging
[8] Hôpital Lariboisière-AP-HP & Université Diderot-Paris 7,Department of Intensive Care
[9] Hôpital Saint-Louis-AP-HP & Université Diderot-Paris 7,Department of Biostatistics and Clinical Epidemiology
来源：
Annals of Surgical Oncology | 2014年 / 21卷
关键词：
Bevacizumab; Propensity Score; Oxaliplatin; Peritoneal Carcinomatosis; Intraperitoneal Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1792 / 1800
页数：8
相关论文
共 50 条
  • [1] Bevacizumab Doubles the Early Postoperative Complication Rate after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis of Colorectal Origin
    Eveno, Clarisse
    Passot, Guillaume
    Goere, Diane
    Soyer, Philippe
    Gayat, Etienne
    Glehen, Olivier
    Elias, Dominique
    Pocard, Marc
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) : 1792 - 1800
  • [2] Influence of bevacizumab on early postoperative complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin.
    Eveno, Clarisse
    Glehen, Olivier
    Goere, Diane
    Lukaszewicz, Anne-Claire
    Passot, Guillaume
    Elias, Dominique
    Pocard, Marc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Bevacizumab before cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin: Analysis of early postoperative complication rate and long term follow-up
    Eveno, Clarisse
    Passot, Guillaume
    Goere, Diane
    Soyer, Philippe
    Gayat, Etienne
    Glehen, Olivier
    Elias, Dominique
    Pocard, Marc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis of colorectal origin
    Cioppa, T.
    Vaira, M.
    Bing, C.
    D'Amico, S.
    Caponi, A.
    Fiorentin, G.
    De Simone, M.
    [J]. GIORNALE DI CHIRURGIA, 2009, 30 (05): : 196 - 200
  • [5] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis
    Pallas, Nicolaos
    Karamveri, Christina
    Kyziridis, Dimitrios
    Hristakis, Christos
    Kyriakopoulos, Vasileios
    Kalakonas, Apostolos
    Vaikos, Dimitrios
    Tentes, Antonios-Apostolos K.
    [J]. JOURNAL OF BUON, 2017, 22 (06): : 1547 - 1553
  • [6] RESULTS OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY FOR PERITONEAL CARCINOMATOSIS OF COLORECTAL ORIGIN
    Merayo Alvarez, M.
    Turienzo Santos, E.
    Garcia Munar, M.
    Cifrian Canales, I.
    Rodicio Miravalles, J. L.
    Moreno Gijon, M.
    Sanz Alvarez, L.
    [J]. BRITISH JOURNAL OF SURGERY, 2021, 108 : 17 - 17
  • [7] Early Postoperative Intraperitoneal Chemotherapy (EPIC) after Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Carcinomatosis Results in Greater Morbidity
    Tan, G. H.
    Chia, C.
    Ong, W.
    Soo, K.
    Teo, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S158 - S158
  • [8] Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin
    Adrian Cravioto-Villanueva
    Magdalena Cavazos
    Pedro Luna-Perez
    Hector Martinez-Gomez
    María Lourdes Ramirez
    Juan Solorzano
    Hermelindo Montiel
    Jesus Esquivel
    [J]. Surgery Today, 2016, 46 : 979 - 984
  • [9] Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin
    Cravioto-Villanueva, Adrian
    Cavazos, Magdalena
    Luna-Perez, Pedro
    Martinez-Gomez, Hector
    Lourdes Ramirez, Maria
    Solorzano, Juan
    Montiel, Hermelindo
    Esquivel, Jesus
    [J]. SURGERY TODAY, 2016, 46 (08) : 979 - 984
  • [10] Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.
    Ramírez Plaza C.P.
    Cobo Dols M.A.
    Gómez Portilla A.
    de la Fuente Perucho A.
    [J]. Clinical and Translational Oncology, 2005, 7 (10) : 421 - 431
12345